Contact:
Steve Kelly
Director of Communications
Society for Clinical Research Sites
410.696.5080 x180
stephen.kelly@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes Medidata as a Circle of Sustainability Sponsor

Ellicott City, M.D., July 16, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced that Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, has joined SCRS’ Circle of Sustainability Sponsorship program. The program is designed to facilitate critical dialogue between industry stakeholders and clinical research sites, furthering SCRS’ mission of unifying the site community for greater sustainability.

“SCRS is proud to welcome Medidata as a Circle of Sustainability Sponsor,” said Christine Pierre, SCRS President. “The forward momentum of the clinical research industry is contingent upon improved relationships between sites, industry stakeholders, and solution-providers such as Medidata. This high-level partnership is symbolic of Medidata’s deep commitment to creating a more sustainable future for sites globally.”

As part of this program, Medidata’s president Glen de Vries will serve on the SCRS Global Impact Board, working with the organization’s leadership council to determine strategic initiatives for the society. Additionally, Medidata will sponsor and moderate the “Site Tank” session at the 2015 Global Site Solutions Summit in Amelia Island, Florida on October 8-11. During the session, which will take place on October 11 at 10:05 am, representatives from research sites will share innovative ideas on how technology can be used to enhance clinical trial operations.

“Our partnership with SCRS reflects Medidata’s dedication to ensuring research sites have the technology and resources they need to optimize productivity, gather high-quality data and create better patient experiences,” said de Vries. “We’re pleased to support SCRS and the important dialogue the society is facilitating to help the industry move clinical research forward.”

####

About SCRS

SCRS is a global trade organization founded in 2012 that represents over 2,600 research sites, including 30,000 research professionals in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About Medidata Solutions

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud® brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Contact:
Diana Foster, PhD
Chief Strategy Officer
Society for Clinical Research Sites
410.696.5080
diana.foster@myscrs.org

FOR IMMEDIATE RELEASE

Sponsor and CRO Finalists Announced for Annual Society for Clinical Research Sites’ Eagle Award

Ellicott City, M.D., August 13, 2015 – The Society for Clinical Research Sites (SCRS), the trade organization representing over 2,600 global clinical research sites in 42 countries, announces today the finalists for the 2015 SCRS Eagle Award. The finalists were selected from a record number of nominations provided by SCRS members. Qualifying nominees were in the 75^th percentile or higher of the total nominations submitted for the Eagle Award. Voting is now open to all clinical research site professionals, regardless of their membership with SCRS, and closes September 14, 2015.

The SCRS Eagle Award recognizes outstanding leadership, professionalism, integrity, and dedication to advancing the clinical research profession through a strong site partnership.

The 2015 sponsor finalists are: Amgen, Astellas, AstraZeneca, Eli Lilly & Company, Ferring Pharmaceuticals Inc., Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, Merck & Co., Nektar, Novavax, Novo Nordisk, and Pfizer.

The 2015 CRO finalists are: INC Research, iVentiv Health, Medpace, PAREXEL International, PRA Health Sciences, Quintiles, and Target Health Inc.

Christine Pierre, President of SCRS, states: “SCRS congratulates this year’s Eagle Award finalists and looks forward to announcing the Sponsor and CRO recipients during the Eagle Award Gala. The Eagle Award is consistent with SCRS’ mission that partnerships between sites and sponsors and CROs are critical for our collective success. When sponsors and CROs weigh the value the site brings to each project, authentic communication is created, leading to greater collaborative performance.”

Sites strive to work with companies that truly value them as a partner in the clinical trial process. When sponsors and CROs weigh the value the site brings to each project, authentic communication is created, leading to greater collaborative performance. SCRS Eagle Award nominees are finalized through direct site input. The voice of the sites is being heard loud and clear: more nominations have been received this year than ever before. To SCRS, this signifies the eagerness among sites to appreciate and publicly recognize companies who demonstrate a strong commitment to the site partnership. SCRS congratulates each Eagle Award finalist.

Winners will be honored at the 2015 SCRS Eagle Award Gala on Saturday, October 10^th in Amelia Island, Florida during the 10^th Annual Global Site Solutions Summit.

####

About SCRS

SCRS is a global trade organization founded in 2012 that represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org

About the Site Solutions Summit

The Global Site Solutions Summit is the annual meeting of the Society for Clinical Research Sites. The Summit provides an open forum for industry and sites to collaborate, share best practices, and improve processes in clinical research. Held October 8-11 at the Omni in Amelia Island, FL, the Global Site Solutions Summit attracts investigators and site executives from research sites across the globe, as well as clinical operation executives from sponsor and CRO organizations.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes goBalto as New Global Impact Partner

Ellicott City, M.D., July 15, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with goBalto, the leading provider of cloud-based clinical study startup solutions. goBalto will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“goBalto represents a handful of technology solution companies that have openly endorsed their commitment to clinical research sites”, said Christine Pierre, SCRS President. “SCRS’ GIPs are focused on acknowledging the realities that today’s sites face, and actively addressing their challenges. goBalto is bringing technology disruptions to the cumbersome and inefficient clinical trial process and we are proud to welcome them as our newest Global Impact Partner.”

Jae Chung, goBalto’s President and Founder stated, “As a company dedicated to delivering innovative technologies that guide work and help standardize global processes by mitigating clinical risk and operational cycle times via “smart” workflows, we recognize the critical role clinical research sites play as collaborators in fulfilling this mission.”

“The SCRS collective voice of global clinical research sites guides our development efforts and our industry adoption,” added Chung. “We now service three of the top 5 CROs and more than two-thirds of the top 20 pharma’s, representing > 70% of clinical trial sites in phase II & III of the top 25 pharma companies at over 18,000 sites.” As a Global Impact Partner (GIP), goBalto will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

####

About SCRS

SCRS is a global trade organization founded in 2012 that represents over 2,600 research sites, including 30,000 research professionals in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About goBalto

goBalto develops next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries. Our management team has over 100 years of combined experience in the life sciences industry and enterprise software implementation. Our team has worked for such companies as Amgen, Genentech, Quintiles, Roche, Johnson & Johnson, and Model N. With a proven commitment to customer success, disruption, and study startup optimization, we’re changing the way our leading global pharma and CRO customers approach their business processes. Based in San Francisco, California, we have satellite offices in Pennsylvania and Singapore. For more information, visit www.gobalto.com

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Lilly to Host Site Partnership Symposium at Global Site Solutions Summit

Ellicott City, MD – September 11, 2015: The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests and voice of clinical research sites, today announced that Lilly will host a Site Partnership Symposium at the Global Site Solutions Summit in October. The symposium is scheduled for Thursday, October 8, from 2:00 pm – 4:00 pm.

During the symposium Lilly will share insights with sites on their program portfolio, how potential protocol challenges can be identified; critically evaluate a study for resource consumption and patient burden; and their views on advocating for sites and patients. This exciting symposium will feature interactive dialogue between attending sites and the Lilly team.

The SCRS Site Partnership Symposium is a new program feature for the 2015 Global Site Solutions Summit, which will take place October 8-11, 2015, in Amelia Island, FL. The Symposium is an unprecedented format through which leading sponsors and CROs engage in high-level dialogue and directly interact with up to hundreds of site decision makers. The Symposium focuses on promoting knowledge and mobilizing insight into study pipeline opportunities and will be included as part of every site executive’s admission to the Global Summit.

SCRS President Christine Pierre said “Lilly has been a significant supporter of SCRS since its inception and we continue to appreciate their ongoing collaboration with SCRS on behalf of the site community. The symposium is yet another example of Lilly’s commitment to the sustainability of sites and the research community.

###

About SCRS

SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes PAREXEL as New Global Impact Partner

Ellicott City, M.D., October 1, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with PAREXEL, a leading biopharmaceutical services company that provides a broad-range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. PAREXEL will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

Christine Pierre, President of SCRS shared “It’s wonderful having PAREXEL showing their support of the sites through their collaboration with SCRS as a Global Impact Partner. This decision reinforces why PAREXEL has been selected by the sites as one of the CRO finalists of the 2015 SCRS Eagle Award. We welcome the opportunity for further collaboration between the two organizations.”

“At PAREXEL, we are committed to simplifying the drug development journey for our clients. The role of clinical research sites in the journey is a key part of our ability to achieve this mission for our clients and their patients,” said Dominic Clavell, Global Head of Site Alliances, PAREXEL. “We are pleased to collaborate with the Society for Clinical Research Sites as a Global Impact Partner to ensure greater collaboration and communication with clinical research sites.”

As a Global Impact Partner (GIP), PAREXEL will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

####

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,660 employees in the fourth quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes the Nomination of Dr. Robert Califf as FDA Commissioner

Ellicott City, M.D., October 5, 2015 – Christine Pierre, President of the Society for Clinical Research Sites (SCRS), today issued the following statement on President Barack Obama’s Sept. 15 nomination of Dr. Robert Califf to serve as the next Commissioner of the Food and Drug Administration:

“SCRS welcomes the nomination of Dr. Califf as FDA Commissioner. Rob has worked closely with SCRS on many initiatives including being a member of SCRS’ Leadership Council and also on many projects through the Clinical Trials Transformation Initiative. His extensive experience and commitment to the ethical and efficient process needed to conduct research will be an invaluable foundation for him to bring to this new role. Rob’s vast experience and unwavering commitment to bringing safe and effective new treatments to patients will greatly benefit the agency and the general public.”

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Announces Winning Sponsor and CRO of 2015 Eagle Award – Merck & Co. and Quintiles

Ellicott City, M.D., October 13, 2015 – The Society for Clinical Research Sites (SCRS), the first global trade organization fully dedicated to representing the interests of clinical research sites, announced at its 2015 Global Site Solutions Summit that Merck & Co. is the winning sponsor of the 2015 Eagle Award, and Quintiles garnered honors as the winning CRO.

Since 2009, the Eagle Award annually has recognized the sponsor and CRO organizations that are dedicated to creating positive relationships with sites, as voted on by the sites. Winners are judged according to their outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through a strong site partnership.

This year’s winners were chosen from a record number of nominations from SCRS members and almost 3,000 votes cast by sites from around the globe.

“One of our primary goals is to be a ‘partner of choice’ with all of our constituencies,” said Andy Lee, Senior Vice President and Head of Global Clinical Trial Operations at Merck.  “Winning the 2015 Eagle Award is spectacular news and clear acknowledgement that our efforts to form solid relationships with investigators and clinical sites is recognized and appreciated. For that we can thank our clinical monitoring team and our efforts to implement new strategies that put monitoring front and center in developing strong ties with sites, including hiring Mark Travers in a new position as Head of Monitoring Excellence at Merck.  Monitoring is a core competency for our company.  I want to thank SCRS for the excellent job they do in pulling together the collective view of this segment of our industry.”

“It is a tremendous honor to be recognized for this award three years in a row,” said Jeanne Hecht, senior vice president and global head, Site & Patient Networks at Quintiles. “This award reflects Quintiles’ commitment to continually enhancing site relationships. I would like to thank our dedicated employees at Quintiles, as well as the talented individuals and teams with whom we work at investigator sites around the world. Together we have a relentless focus to accelerate the delivery of needed therapies to patients.”

“The winning sponsor and CRO of the 2015 Eagle Award were selected exclusively on votes cast from the sites,” states Christine Pierre, SCRS President. “From the record number of votes cast this year, it is clear there was great enthusiasm to recognize the sponsor and CRO who have exemplified an exceptional working relationship with the sites. SCRS applauds the efforts of Merck & Co. and Quintiles to raise the industry standards by initiating strong partnerships with the clinical research sites.”

The selection criteria for finalists included a willingness to collaborate on protocol design and execution, availability of a qualified staff to support the sites, financial consideration to the sites, and potential for future partnership. SCRS members nominated the sponsor and CRO they had worked with in the past 18 months that they believed exemplified these characteristics. The final nominees were sponsors and CROs that ranked in the 75th percentile or higher of initial nominations.

In addition to Merck & Co., this year’s sponsor finalists for the Eagle Award were: Amgen, Astellas, AstraZeneca, Ferring Pharmaceuticals Inc., Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, Lilly, Nektar, Novavax, Novo Nordisk, and Pfizer.

Joining Quintiles as the 2015 CRO finalists were: INC Research, iVentiv Health, Medpace, PAREXEL International, PRA Health Sciences, and Target Health.

The 2016 Site Solutions Summit will be held October 13-16, 2016 at the Boca Raton Resort and Club, a Waldorf Astoria Resort in Boca Raton, Florida.

###

About SCRS

SCRS is a global trade organization founded in 2012 that represents more than 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Applauds SPRIA Winner – Mzansi Ethical Research Centre

Ellicott City, MD, October 14, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, announced at its annual Global Site Solutions Summit that Mzansi Ethical Research Centre is the winner of the second annual Site Patient Recruitment Innovation Award (SPRIA), which recognizes sites that employ innovative strategies to achieve enrollment success.

“It was very humbling to be recognized by our peers as the winner of this year’s SPRIA. The award is recognition of our entire team’s effort,” said Dr. Mohammed Siddique Tayob. “What we presented were ideas we have learned from industry. SCRS is a platform that will continue to drive the industry forward. Sites around the world need to become involved with SCRS or they will become irrelevant. We are inspired and are taking so much home with us from the 2015 Global Site Solutions Summit.”

SCRS launched the SPRIA at its 2014 Site Solutions Summit to recognize sites that implemented innovative recruitment plans. This year, four finalists were chosen by an independent judging panel from among more 20 submissions from sites around the globe.

The winner was chosen by a panel of judges who, in assessing the plans, looked for innovative patient-directed initiatives that were unique, effective and took into account the response of the campaign. The judges were Todd Albin, Senior Director, Site Enrollment Optimization, Acurian; Gretchen Goller, Senior Director, PRA Health Sciences; Len Jokubaitis, MD, Clinical Operations Head, Medical Affairs-Americas Region, Janssen Research & Development, LLC; and Steve Swanson, President and CEO, DAC Patient Recruitment Services.

“The SPRIA is designed to recognize the sites that demonstrates an effective and innovative recruitment plan. Each of the finalists is to be congratulated on their site’s achievement,” states Christine Pierre, President of SCRS. “SCRS is committed to site sustainability and through sharing such innovative and best practices we are confident that all will benefit. SCRS sincerely congratulates Mzansi Ethical Research Centre, the 2015 SPRIA winner and thanks Acurian for their support of this award ceremony.”

In addition to Mzansi Ethical Research Centre, the 2015 SPRIA finalists were Compass Research, Research Institute of Deaconess Clinic, and Sunrise Medical Research. The finalists presented their innovative recruitment plans to an audience of sites, sponsors, and CROs who attended the Global Summit, which was held October 8-11, 2015 in Amelia Island, Florida.

The 2016 Site Solutions Summit will be held October 13-16, 2016 at the Boca Raton Resort and Club, a Waldorf Astoria Resort in Boca Raton, Florida.

###

About SCRS

SCRS is a global trade organization founded in 2012 that represents more than 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Congratulates Inaugural Site Tank Winner – Sheridan Clinical Research

Ellicott City, M.D., October 14, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests and voice of clinical research sites, announces that Sheridan Clinical Research is the winner of its popular “Site Tank” award, which was presented at SCRS’s 2015 Global Site Solutions Summit on October 11, 2015.

The Site Tank award allowed sites to share at the Global Site Solutions Summit innovative technology concepts designed to enhance, empower and improve their sites. Medidata Solutions sponsored Site Tank and will consider conceptualizing a proof of concept of Sheridan Clinical Research’s winning idea.

“It is an honor to be the inaugural winner of “Site Tank” at the 2015 SCRS Summit. It was a thrilling opportunity to present an idea to the best and brightest IT industry technology leaders and my peers,” said Deena Bernstein of Sheridan Clinical Research. “I look forward to seeing this idea come to fruition providing transparency of Sponsor/CRO grant systems, site CTMS, and EDC. The sites need a fully automated way to reconcile and receive payments. In the spirit of collaboration amongst the stakeholders this solution will be a phenomenal advancement.”

“The Site Tank was an idea conceptualized by me and Glen when discussing ways to provide technology solutions sites want and need, but that the developers are often unaware of,” stated Christine Pierre, President of SCRS. “Site Tank provides a unique format to ensure the site’s voice is being heard, a mission of SCRS. SCRS is appreciative of Medidata for their support of the event and their commitment to harmonize the technology processes sites must interface with when conducting clinical trials. Congratulations to Sheridan Clinical Research as the Site Tank winner.”

Sheridan Clinical Research was among more than a dozen ideas submitted. In addition to Sheridan Clinical Research, this year’s finalists were Oklahoma Heart Hospital Research Foundation and Reading Hospital. The ideas were reviewed by an independent judging panel, which chose three finalists to present their ideas at the Global Summit. There, the judges queried the finalists about their ideas before a live audience, which voted on the winner. The judges were Jae Chang, Founder and President, GoBalto; Jeff Kasher, President of Patients Can’t Wait; Jackie Kent, Senior Director of Clinical Development Information and Optimization & NGD Trial Execution at Lilly; and Hugo Stephenson, Executive Chairman, DrugDev. Glen de Vries, President of Medidata Solutions, acted as the event’s moderator.

The 2016 Site Solutions Summit will be held October 13-16, 2016 at the Boca Raton Resort and Club, a Waldorf Astoria Resort in Boca Raton, Florida and will again host the Site Tank event.

###

About SCRS

SCRS is a global trade organization founded in 2012 that represents more than 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Celebrates the Medical Heroes with 5K Fun Run and Walk

Ellicott City, M.D., October 22, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, held the second annual 5K Fun Run/3K Walk to celebrate study patients on Sunday, October 11, 2015 in Amelia Island, Florida at the Site Solutions Summit. DAC Patient Recruitment Services sponsored the 5K and raised over $3,200 for The Center for Information & Study on Clinical Research Participation (CISCRP) to continue to promote awareness for their Medical Heroes Program. SCRS matched the proceeds with their own donation at the Summit.

Christine Pierre, President of SCRS shares “we are proud to celebrate the real heroes, the study patients and their important contribution to medicine and are deeply thankful for the generous support of our participants. Together, we will continue to make a difference to the clinical trials community while engaging in a fun and healthy activity.”

“Anytime we, as a company, are able to acknowledge the true heroes within clinical research, we endeavor to do so. Through our sponsoring of the 5K run at this year’s Summit, we’re able to acknowledge the value of patients by supporting a worthwhile organization” shared Steve Swanson, President of the Imperial Family of Companies and CEO of DAC.

####

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites, in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About DAC Patient Recruitment Services
A pioneer in patient recruitment for clinical trials since 1992, DAC Patient Recruitment Services offers strategic site selection, country-customized patient recruitment and retention, award-winning creative services, and CEU-certified global clinical staff training. DAC has successfully managed recruitment and retention for clinical trial projects involving 100,000 patients across 16,000 sites in 100 countries.

About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) was founded in 2013, and is a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. As part of its mission, CISCRP provides a variety of award-winning resources, programs and services that are designed to assist clinical research stakeholders in understanding public and patient attitudes and experiences in research as well as improving volunteer participation experiences and satisfaction. Visit CISCRP.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
410.696.5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes ICON as New Global Impact Partner

Ellicott City, M.D., November 5, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON will participate as a Global Impact Partner (GIP) and align with 31 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“ICON’s relationship with SCRS reinforces their commitment to strengthening site partnerships and furthering alliance with industry stakeholders,” commented Christine Pierre, SCRS President. “Collaboration with ICON is a significant strategic development for SCRS, and we are extremely pleased to welcome them as our newest GIP.”

“Building a close connection with research sites and patients is an integral part of helping our clients to take time and cost from their development programmes,” commented Lollo Eriksson, Executive Vice President, Site and Patient Recruitment, ICON. “We are pleased to collaborate with the SCRS as a Global Impact Partner and we look forward to working with them to promote global clinical research and building patient awareness. Our partnership with SCRS, together with our work with IBM Watson Clinical Trial Matching are examples of some of the initiatives we are working on to enhance patient recruitment and study start-up.”

As a Global Impact Partner (GIP), ICON will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

####

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

About ICON
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 77 locations in 38 countries and has approximately 11,700 employees. More information is at www.iconplc.com

Contact:
Kim Howard, CAE
Director of Communications
Society for Clinical Research Sites
(410) 696-5080 x210
kim.howard@myscrs.org

FOR IMMEDIATE RELEASE

HealthCarePoint BlueCloud® Renews its Global Impact Partnership with the Society for Clinical Research Sites

Ellicott City, MD, November 30, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced the renewal of a two-year relationship with HealthCarePoint, creators of the BlueCloud® (nominated as one of the top business and technology innovations of 2015). HealthCarePoint’s mission is to do everything possible to improve the healthcare and clinical research systems by increasing transparency and becoming more accountable to patients, subjects and the public in general. HealthCarePoint will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“When Global Impact Partners renew their partnership with us, it’s because they are as committed to the sites as we are. It speaks volumes about SCRS as we continue our work in tandem with partners like HealthCarePoint who also want our profession to be the best that it can be. We are excited to continue working with them,” said Christine Pierre, president of SCRS.

“Part of our mission is to support organizations that have a passion, drive and motivation to make a difference in our industry,” said Al O. Pacino, President of HealthCarePoint. “From the beginning, we have had a strong supporting relationship with SCRS. Our missions underline the mutual support for the continued effort of long term site sustainability. We are happy to continue to work in tandem partnership for the benefit of investigator sites worldwide.”

As a Global Impact Partner (GIP), HealthCarePoint will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About HealthCarePoint
HealthCarePoint’s BlueCloud® e-applications are used in 162 countries by over 750,000 healthcare professionals, 42 Sponsors, 14 CROs, 8 IRBs, dozens of universities and thousands of healthcare organizations. BlueCloud® e-applications work together as one system, empowering industry stakeholders to organize, centralize, connect, share and deliver information, credentials, education, training, standards and other activities, between organizations in “real-time” saving our industry millions of dollars in duplication, wasted time and unnecessary redundancies. After a 13-year incubation period, BlueCloud® is no longer and unproven concept, but a true reality that is saving industry stakeholders’ time, money and ultimately saving lives. Visit HealthCarePoint.com.

Contact:
Kim Howard, CAE
Director of Communications
Society for Clinical Research Sites
(410) 696-5080 x210
kim.howard@myscrs.org

FOR IMMEDIATE RELEASE

Bio-Optronics Renews Its Global Impact Partnership with the Society for Clinical Research Sites

Ellicott City, MD, December 2, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced the renewal of a two-year relationship with Bio-Optronics, a leading healthcare information technology company, focusing specifically on workflow optimization. Bio-Optronics will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

Christine Pierre, president of SCRS, said, “We are thrilled to have Bio-Optronics continue to show their support of the sites through their collaboration with SCRS as a Global Impact Partner. We welcome the opportunity for further collaboration between the two organizations.”

“SCRS continues to serve as a the most prominent resource for the research site community to thrive and collectively grow, and we are eager to continue this partnership, serve as a resource to the site community and continue to grow Clinical Conductor CTMS to further accommodate the needs of research sites,” stated Maria Durkin, Chief Business Officer of Bio-Optronics.

As a Global Impact Partner (GIP), Bio-Optronics will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About Bio-Optronics
Since 1985, Bio-Optronics has created unique and innovative software solutions for hospitals and hospital networks, medical practices, imaging centers and all participants in the clinical trial enterprise. Its mission is to develop and deploy software products and services to help healthcare professionals enhance quality, productivity and patient and staff satisfaction.

Contact:
Allyson Small
Director of Membership
Society for Clinical Research Sites
(410) 696-5080 x130
allyson.small@myscrs.org

FOR IMMEDIATE RELEASE

TransCelerate BioPharma Launches the
Shared Investigator Platform to Revolutionize Communications between Sites and Sponsors

Philadelphia, PA, January 20, 2016 – TransCelerate BioPharma Inc. today announced the launch of the Shared Investigator Platform (SIP), a technology that will allow clinical trial sites to streamline investigative site information, and establish a central access point for interaction between the site and multiple clinical trial sponsors.

The unique design and development of the SIP was made possible through important partnerships with several key stakeholders. To ensure the investigator site perspective was included in the design of the system, participating TransCelerate Member Companies collaborated with Investigators through a Site Advocacy Group provided through a partnership with the Society for Clinical Research Sites (SCRS). The interface for the delivery of content and services to sites was developed by Cognizant, the overall system integrator and service provider who was selected to design, build and host the SIP. Cognizant incorporated capabilities by CA Technologies, DrugDev, Exostar, LifeRay and SumTotal each who played a critical role in bringing the innovative vision of the TransCelerate Member Companies to life.

Clinical research sites often have to use written documents, as well as multiple portals or applications requiring separate login accounts to perform clinical trial responsibilities for each sponsor with whom they work. As a result, communication for sites who work with multiple sponsors and across multiple studies has been cumbersome and complex. Moreover, the development and maintenance of individual sponsor portals has made operations unnecessarily costly and time-consuming.

Shared Investigator Platform Initiative Leader Jackie Kent, and Eli Lilly’s Senior Director, Product Delivery Supply Planning and Systems, states, “The SIP will help us, as an industry, solve operational R&D challenges common to trial sites and sponsors. With SIP, sponsors and sites will benefit from improvements in study start up or reduction in duplicative work.”

Ms. Kent goes on to note, “SIP benefits the patient by reducing the amount of time investigators dedicate to onerous administrative tasks, elevating the focus on the patient experience – a critical element to a trial’s overall success and a key strategic priority for TransCelerate. Our ultimate goal at TransCelerate is to ensure that medicines are delivered to patients quickly and safely, and the SIP plays a pivotal role in realizing that.”

The Shared Investigator Platform is closely connected to TransCelerate’s Investigator Registry (IR) Initiative, a shared repository of investigator details. The IR links together profiles from the Shared Investigator Platform with TransCelerate Member Companies’ clinical trial management systems, the DrugDev investigator network, public data and other third party sources using the universal identifier, known as the DrugDev Golden Number. The aim of the TransCelerate IR is to provide an evidence-driven approach for accelerating the identification and recruitment of qualified investigators, also providing participating TransCelerate Member Companies with a mechanism to prevent duplication of site qualification activities or generation of investigator documents.

TransCelerate’s CEO, Dalvir Gill, PhD, states, “The development of the Shared Investigator Platform was one of TransCelerate’s founding initiatives aimed at reducing investigative site burden. The SIP and the supportive Investigator Registry combined should dramatically decrease the administrative burden placed on investigator sites and improve sponsor efficiencies.” Several TransCelerate Member Companies have announced plans to adopt SIP and IR in the near term, and the clear benefits from SIP and IR will lead others to adopt future releases in 2016 and beyond. This release marks just the beginning for the Shared Investigator Platform. Future releases of the platform will add more functions and capabilities to further promote efficiency for investigator sites conducting clinical studies.

What Does SIP Go-Live Mean For Research Sites?
The SIP will facilitate and simplify interaction between investigators and multiple clinical trial sponsors. With the SIP, sites will experience:

• Increased efficiency and reduced administrative burden in clinical trial planning & conduct.
• Streamlined interactions, and consistent data & processes with participating SIP Sponsors.
• Reduction of data entry requirements – the ability to enter data once, and have that data re-used across SIP Studies and Sponsors.

With SIP, sites can maintain more meaningful collaborations with Sponsors and investigators spend more time on what matters most – their patients.

To learn more about the Shared Investigator Platform visit: http://www.transceleratebiopharmainc.com/initiatives/shared-investigator-platform/.
Also, watch our video for a brief overview on SIP here:
http://www.transceleratebiopharmainc.com/videos/whatissip/.

###

About TransCelerate BioPharma Inc.
TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by accelerating and enhancing the research and development (R&D) of innovative new therapies. The organizations’ mission is to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines. TransCelerate evolved from conversations at various forums for executive R&D leadership to discuss current issues facing the industry, and examine solutions for addressing common challenges. The founding member companies are AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, the Roche Group, and Sanofi. Additional members that have joined since the inception of TransCelerate include Allergan, Inc., Amgen, Astellas Pharma Inc., EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Medgenics, Inc., Merck & Co., Inc., Novo Nordisk, Shionogi & Co., Ltd. and UCB.
Membership in TransCelerate is open to pharmaceutical and biotechnology companies with Research & Development operations. Executive offices are located in Philadelphia, PA. For more information, please visit http://www.transceleratebiopharmainc.com.

Follow us on Twitter: https://twitter.com/transcelerate
Reach us on LinkedIn: www.linkedin.com/company/transcelerate-biopharma-inc-

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
(410) 696-5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Adds Oracle as a New Global Impact Partner

Ellicott City, MD, January 26, 2016 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with Oracle, who provides integrated cloud application, platform services and engineered systems. Oracle will participate as a Global Impact Partner (GIP) and align with 33 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“We are excited to have a company like Oracle included in our Global Impact Partner program. They will bring a unique perspective to the table for both the sites and our other GIPs. Diversifying our GIPs adds bench strength to our organization which makes us stronger,” said Christine Pierre, president of SCRS.

As a Global Impact Partner (GIP), Oracle will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About Oracle
With more than 420,000 customers—including 100 of the Fortune® 100—and with deployment across a wide variety of industries in more than 145 countries, Oracle offers a comprehensive and fully integrated stack of cloud applications, platform services and engineered systems.

Contact:
Lori Dorer
Senior Director, Corporate Communications
INC Research
(513) 763-1360
Corporate.Communications@incresearch.com

FOR IMMEDIATE RELEASE

INC Research Expands Partnership With Society for Clinical Research Sites to Enhance Site Sustainability on a Global Basis

RALEIGH, N.C., Feb. 22, 2016 – INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the expansion of its partnership with the Society for Clinical Research Sites (SCRS), further demonstrating the Company’s continued commitment and leadership role in fostering strong site relationships globally. INC is the first
organization to become a Circle of Innovation sponsor, a new level of commitment and the highest level of sponsorship aimed at increasing site support and site sustainability globally. Under the expanded partnership agreement, INC will be a lead supporter of SCRS’ new Ambassador Program, which aims to extend SCRS membership and support to sites globally through regional activity around the world.

“INC Research has continued to grow our relationship with SCRS because our two organizations are well aligned in our shared commitment to site sustainability and providing sites across the globe a stronger voice in the clinical development process,” said Clare Grace, PhD, Vice President, Site and Patient Access. “We are excited to be part of SCRS’ new Ambassador Program to expand vital support to even more sites around the world. Our initial focus will be on connecting with sites in the Asia/Pacific region. Through our participation, we can help facilitate better communication and work in a more collaborative way to address the unique needs and challenges these sites face, ultimately improving site support and sustainability.” “The Ambassador Program offers a unique opportunity for organizations to participate in an unprecedented experience supporting site development and sustainability at a local and regional level,” said Christine Pierre, President, SCRS. “INC Research has been very supportive of our mission and purpose to further expand our efforts globally. We’re excited to advance our partnership to the next level through the launch of this program and see INC as playing a pivotal role as we work to support site development and sustainability on a more global scale.”

As a Circle of Innovation sponsor, INC Research initially will sponsor the Ambassador Program in Australia, Japan, Korea, New Zealand, Taiwan and the United Kingdom and will provide scholarships for membership in SCRS to sites new to SCRS in these regions. In addition the Company will expand its use of Site Advocacy Groups (SAGs) in 2016 to better incorporate the site voice in the conduct of clinical trials in fast-growing therapeutic areas representing significant patient need. These efforts will build on INC’s existing SAGs established in 2015 devoted to the scientific and operational aspects of psychiatry protocols and the streamlining and enhancing of the payment process for clinical research sites. INC Research will continue as a Global Impact Partner to SCRS, serving on its Global Impact Board and Leadership Council and serving as a lead sponsor for its site solutions summit events focused on sharing best practice in clinical research.

INC Research is focused on connecting customers, sites and patients to improve world health. Ranked the “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey, the Company is committed to developing and nurturing deep site relationships that ensure rapid study start-up, smooth study conduct and consistently excellent results for its customers. The Company recently announced the launch of its Catalyst program to strengthen collaborations with clinical research sites worldwide, in turn enhancing patient focus and optimizing study delivery to drive improved predictability of clinical trials and reduce development timelines for biopharmaceutical customers. INC’s Catalyst program includes the Catalyst Site Network, a select group of high-performing sites strategically and therapeutically aligned both to its business and its customers, and the Catalyst Community, which is an online forum representing a broader range of sites to support ongoing communication on the conduct of clinical trials, wider adoption of new methodologies and the sharing of best practice.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization (“CRO”) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.

Congratulations to Robert Califf, MD, former CTTI co-chair, on his confirmation as FDA Commissioner. Throughout his career, Dr. Califf has made considerable contributions to clinical care, clinical research and public health policy. CTTI colleagues have seen firsthand his commitment and leadership to improving clinical trials for the benefit of all patients. We are excited that he will have an opportunity to continue his dedicated service to improving the public’s health as the leader of the FDA.

A report on the decision from the Senate is located at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm487455.htm.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
(410) 696-5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes Merge eClinical as a New Site Engagement Partner

Ellicott City, MD, March 1, 2016 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced an expanded partnership with the eClinical division of Merge Healthcare, an IBM company. Merge is a leading provider of software solutions for the clinical research industry.

“We are pleased to have Merge’s support for a number of important initiatives and member programs,” said Christine Pierre, president of SCRS. “This level of partnership is symbolic of Merge’s deep commitment to creating a sustainable future for clinical research sites globally.”

As a Site Engagement Partner, Merge will continue to participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About Merge eClinical
The eClinical division of Merge Healthcare, an IBM Company, is a leading provider of cloud-based software solutions for the clinical research industry. Our flagship products include eClinicalOS (eCOS) and CTMS for Investigators (CTMSi). eCOS is a single, scalable platform that allows Sponsors, CROs, and academic researchers to capture and manage clinical data with ease. CTMSi is a comprehensive clinical trial management system that helps site professionals organize and centralize the study management process. Get more information at www.eclinicalos.com.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
(410) 696-5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes Nimblify, Inc., as a New Global Impact Partner

Ellicott City, MD, March 10, 2016 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with Nimblify, Inc., developers of technologies that create industry-wide efficiencies in clinical research. Nimblify will participate as a Global Impact Partner (GIP) and align with 33 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“Nimblify’s commitment to become a GIP is indicative of their eagerness to strengthening site partnerships and accelerating collaboration amongst industry stakeholders. Collaboration with Nimblify is a significant strategic development for SCRS and we are pleased to welcome them to our community” commented Christine Pierre, SCRS President.

“I want to congratulate Christine and SCRS for bringing together a vibrant site community. We are quite excited to join as a Global Impact Partner,” said Shree Kalluri, Nimblify Founder & CEO. “We are particularly eager to partner with SCRS on the Site Score Card Initiative to bring Research Resonance Network to their sites, providing free comparative analytics and performance snapshots that can be shared with sponsors,” added Kalluri. “Collaborating with research sites is core to who we are, so this partnership feels very natural to us. Together, with SCRS, we look forward to making great contributions in moving this industry forward.”

As a Global Impact Partner (GIP), Nimblify will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About Nimblify
Nimblify, Inc. is a clinical trials technology company dedicated to creating industry-wide efficiencies by connecting stakeholders in clinical research. Nimblify created Participant Payments, a patient-centric payment system, and hosts Research Resonance Network, an award-winning benchmarking tool that uses a standard set of operational metrics and is free for sites. Nimblify also hosts the Protocol Calendar Exchange, a robust repository of pre-built, pre-reviewed protocol calendars available for clinical trial management systems. Spun out of Forte Research Systems in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit http://nimblify.com/.

Contact:
Joan McClurg
Senior Project Manager
Society for Clinical Research Sites
(410) 696-5080 x170
joan.mcclurg@myscrs.org

FOR IMMEDIATE RELEASE

Society for Clinical Research Sites Welcomes Medpace as a New Global Impact Partner

Ellicott City, MD, April 11, 2016 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced that Medpace will participate as a Global Impact Partner (GIP) and align with 34 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“Medpace is pleased to be a Global Impact Partner with SCRS,” said Susan E. Burwig, Medpace Senior Vice President, Operations. “Investigational sites continue to drive the success of our industry. Medpace – a CRO noted for quality deliverables – believes we can successfully work with other SCRS members to enhance site relationships to the benefit of all stakeholders.”

“SCRS is proud to partner with Medpace,” said SCRS President, Christine Pierre. “Collaboration with leading organizations across the clinical research landscape is a critical strategic development for SCRS to realize its mission in supporting sites. This commitment by Medpace speaks to their strong desire to collaborate with the sites perspective and we are pleased to welcome them to SCRS.”

As a Global Impact Partner (GIP), Medpace will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

###

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.

About Medpace
Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious diseases and vaccines, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. With extensive medical expertise, and renowned regulatory affairs department, Medpace employs 2,400 employees and has clinical trial experience in over 50 countries and 6 regions – North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. In addition, Medpace offers integrated imaging, central and bioanalytical lab capabilities, and clinical pharmacology through wholly-owned business units to provide cohesive, streamlined, and standardized trial management. For more information visit the Medpace website at: www.medpace.com.